Benign Prostate EnlargementNCT07357168
Electromagnetic Field Therapy Versus Aerobic Exercise on Prostatic Function in Elderly With Benign Prostatic Hyperplasia
A study testing pulsed electromagnetic field and Treadmill machine in people with Benign Prostate Enlargement, run by Cairo University at 1 site in Egypt.
Trial summary
This study will be carried out on seventy five elderly patients with benign prostatic hyperplasia. Their age will range from 60 to 75 years old. They will be recruited from Hoda Talaat Harb geriatric care center, Helwan governorate, Egypt. Read more about this study
- Who is it for?
- Ages 60 to 75 years, men only
- Conditions the study is for
- Benign Prostate Enlargement
- What is being tested?
- pulsed electromagnetic field and Treadmill machine
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 75 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2026to 20 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 to 75 years
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Seventy five male elderly patients diagnosed with prostatic enlargement (prostate volume is greater than 40 mL) assessed by ultrasonography.
- They had benign prostatic hyperplasia indicated by a serum-based prostate-specific antigen (PSA) of 4.0 - 10 ng/mL
- They had moderate severity of benign prostatic hyperplasia indicated by a score of 8 to 19 according to the American Urological Association Symptom Index.
- They had lower urinary tract symptoms including nocturia, incomplete emptying of the bladder, urinary hesitancy, weak stream, frequency, and urgency leading to the development of acute urinary retention.
Who cannot join
- Previous prostatic surgery.
- Urogenital malformations, genetic syndromes, and ongoing tumors.
- Uncontrolled hypertension
- Pacemakers and automatic implantable cardioverter defibrillators.
- Neurological disorders such as Parkinson's disease.
- Prostate cancer.
- Patients taking medications that affected bladder function such as antihistamines, decongestants, diuretics, opiates, and tricyclic antidepressants.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Electromagnetic Field Therapy Versus Aerobic Exercise on Prostatic Function in Elderly With Benign Prostatic Hyperplasia
This study will be carried out on seventy five elderly patients with benign prostatic hyperplasia. Their age will range from 60 to 75 years old. They will be recruited from Hoda Talaat Harb geriatric care center, Helwan governorate, Egypt. The aim of this study to investigate the effect of Electromagnetic field versus aerobic exercise on benign prostatic hyperplasia. Benign prostatic hyperplasia is a nonmalignant enlargement of the prostate gland and refers to the stromal and glandular epithelial hyperplasia that occurs in the transition zone of the prostate Clinically, the condition manifests with lower urinary tract symptoms (LUTS) consisting of obstructive (weak urination stream, incomplete bladder emptying, hesitancy) and irritative symptoms (frequency, urgency, nocturia). It is important to note that LUTS can result from a variety of conditions including problems relating to bladder innervation and aging as well as the outflow obstruction caused by BPH. LUTS due to BPH increases with age, BPH was primarily treated surgically for many years, however, in the 1990s this was superseded by the medical approaches that are now the front line therapy. 5α-reductase inhibitors such as finasteride and dutasteride and α-adrenergic blockers such as doxazosin and tamsulosin are used to shrink and relax the organ, respectively. The MTOPS study demonstrated that a combination of the α-blocker Doxazosin and the 5α-reductase inhibitor Finasteride are more effective at reducing LUTS progression than either drug given alone. While these approaches are effective in many patients, a significant proportion, in the range of 35%, showed progressive disease even in the face of the two drug combination,The Electromagnetic field is thought to have the ability to affect the cells that induce different cellular changes , present studies prove that molecular synergies may not remain the unique determinants implicated in the biological interface. EMF possesses numerous well-reported biological effects including inflammation and pain suppression. This therapy is noninvasive, secure, and easy to use for treating the origin of discomfort, damage, and inflammation
Read the detailed description
Benign prostatic hyperplasia (BPH) is a condition in which the prostate gland grows larger than normal, but the growth is not caused by cancer .The prostate has two main growth phases. The first growth phase happens early in puberty when the prostate doubles in size. The second growth phase starts around age 25 and continues throughout life. BPH often occurs late in the second growth phase Experts estimate that BPH affects 5% to 6% of men ages 40 to 64 and 29% to 33% of those ages 65 and older. BPH is the most common prostate problem in men older than age 50. BPH rarely causes symptoms in men younger than age 40,Benign prostatic hyperplasia (BPH) is a prostate volume (PV) enlargement due to a non-malignant cellular proliferation of the parenchyma and stroma of the gland, mainly in the transition area. BPH is a common age-related pathology, often causing lower urinary tract symptoms (LUTS) due to compression of the urethra by the enlarged prostate, which reduces the quality of life of affected patients , Pulsed electromagnetic field (PEMF) appears to act on BPH through anti-inflammatory and microvascular effects that can translate into symptomatic improvement. Experimental and translational work suggests PEMF improves prostate microcirculation and reduces tissue inflammation markers, which may decrease stromal/epithelial hyperplasia and interstitial edema-mechanisms that plausibly reduce prostate volume and obstructive lower urinary tract symptoms (LUTS). This proposed mechanism is supported by Doppler/ultrasound findings and physiologic measures reported in preclinical and human pilot studies showing improved prostatic blood flow and reduced inflammatory indices after PEMF treatment ,Regular physical exercise has been shown to positively influence benign prostatic hyperplasia (BPH), a common condition in aging men characterized by prostate enlargement and lower urinary tract symptoms (LUTS). The mechanisms by which exercise may improve BPH including hormonal modulation through reducing insulin-like growth factor-1 (IGF-1) and estrogen levels, both of which are linked to prostate growth, while increasing testosterone metabolism, potentially slowing BPH progression Physical activity (PA) has myriad health benefits, which may also extend to protection against BPH and LUTS development and progression. PA has been proposed to protect against BPH/LUTS by several possible mechanisms, including reducing body size, decreasing sympathetic nervous system activity ,The complications of benign prostatic hyperplasia may include: acute urinary retention, chronic, urinary retention, blood in the urine, urinary tract infections (UTIs), bladder damage and kidney damage Pulsed electromagnetic field therapy (PEMF) consists of low-frequency pulsed energy waves (1-50) Hz, that have been employed for many therapeutic purposes mainly because of its anti-inflammatory effect Moreover, many studies have shown that it is a safe procedure, without side effects ,Emerging evidence demonstrates that regular physical activity significantly enhances quality of life for men with benign prostatic hyperplasia (BPH). found that moderate-intensity aerobic exercise (30-60 minutes, 3-5 times weekly) improved International Prostate Symptom Score (IPSS) by an average of 3.2 points and quality of life scores by 1.5 points compared to sedentary controls. The study attributed these benefits to reduced prostatic inflammation and improved pelvic floor muscle function ,Human observational studies and reviews support that higher levels of physical activity-including aerobic modalities-are associated with lower odds of BPH and LUTS. A systematic review and meta analysis of observational studies found that compared to sedentary lifestyle, moderate to vigorous physical activity was linked to a significantly reduced risk of BPH/LUTS. While randomized controlled evidence remains limited and rated as very low certainty, some small trials (including tai chi and pelvic floor training) demonstrated improvements in symptom scores (e.g. IPSS reduction by ~6-8 points) when compared to waiting or conventional treatment. Together, these findings suggest that regular aerobic exercise may reduce urinary frequency, nocturia, urgency, and weak urinary stream associated with BPH, possibly via metabolic and anti inflammatory mechanisms ,The present study aimed to evaluate the comparative effects of pulsed electromagnetic field (PEMF) therapy and aerobic exercise training on prostatic function in elderly males diagnosed with benign prostatic hyperplasia (BPH). Seventy-five participants were randomly assigned into three equal groups: Group (A) received EMF therapy in addition to medical treatment program, Group (B) received aerobic exercise training in addition to medical treatment program, and Group (C) received medical treatment program alone. Baseline characteristics, including age and body mass index (BMI), revealed no statistically significant differences among the three groups, confirming their initial comparability. Following the intervention period, all groups demonstrated significant within-group improvements in clinical measures, including prostate volume, serum prostate-specific antigen (PSA), the International Prostate Symptom Score (IPSS), the American Urological Association Symptom Index (AUA-SI), and the Older People's Quality of Life Questionnaire (OPQOL-35). However, the extent of improvement varied across the groups,All groups showed significant improvements in prostate volume, PSA, IPSS, AUA-SI, and OPQOL-35 scores. However, Group (A) (PEMF) showed the most notable improvements, particularly in symptom scores and quality of life. These outcomes suggested that PEMF therapy may improve prostatic health by reducing inflammation, enhancing vascular function, and modulating cellular activity.
The findings aligned with emerging literature supporting PEMF's regenerative and anti-inflammatory effects, though its application in urology remains underexplored. This study provided promising evidence for incorporating PEMF therapy into physiotherapy for BPH, offering a safe, effective, and well-tolerated alternative to invasive management for elderly patients, This study provided strong evidence supporting that pulsed electromagnetic field (PEMF) therapy as an effective, non-invasive adjunct for managing Benign Prostatic Hyperplasia (BPH) in elderly men. PEMF improved both objective outcomes, such as prostate volume, and subjective measures, including LUTS and quality of life, without the adverse effects often associated with pharmacological or surgical treatments.
- Conditions
- Benign Prostate Enlargement
- Being tested
- pulsed electromagnetic field, Treadmill machine
- Keywords
- electromagnetic, prostaticenlargment, aerobicexercise
- Medical subject headings
- Prostatic Hyperplasia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
pulsed electromagnetic fieldDevice
It was applied for all patient in the study group (A) only for 25 minutes per session, three times per week, for 12 consecutive weeks
Treadmill machineDevice
was applied for all patients in the study group (B) only. Each session started with 10 minutes of warm-up (dynamic stretching mainly of the lower limbs, ten right and left hip rotations, and ten arm rotations forward and backward), followed by treadmill walking for up to 20-30 minutes and ended with a phase of 10 minutes of cool-down. During the training, the patient was asked to correct the posture during walking with verbal instructions.
| Study group | Role | What they receive |
|---|---|---|
| Pulsed electro magnetic field therapy | Active comparator | It was applied for patients in the study group (A) only for 25 minutes per session, three times per week, for 12 consecutive weeks. Receives: Device: pulsed electromagnetic field |
| aerobic exercise training | Active comparator | It was applied for patients in the study group (B) only. Each session started with 10 minutes of warm-up, followed by treadmill walking for up to 20-30 minutes and ended with a phase of 10 minutes of cool-down. Receives: Device: Treadmill machine |
| Routine medical treatment | Other | It was conducted for the three groups (A), (B), and (C). Receives: Device: pulsed electromagnetic field; Device: Treadmill machine |
What is being measured
The primary outcome is the main question the study is designed to answer.
prostate volume
This procedure required little to no special preparation, comfortable clothing. The patient was asked to wear a gown and to lie on his side with his knees toward his chest. To obtain high-quality images, an ultrasound transducer - a plastic cylinder about the size of a finger - was inserted a short distance into the rectum. The transducer was covered with a protective sheath and lubricated with gel.
Measured: 12 weeks
Secondary outcomes (2)
International prostate symptom score (IPSS)
There are 7 questions relating to different symptoms the patient may be experiencing and one question relating to his overall quality of life. Once the patient scored each question, the values were added together to give an indication of the severity of the patient symptoms,The score is graded as 0-7: Mild 8-19: Moderate 20-35: Severe
Measured: 12 weeks
The Older People's Quality of Life Questionnaire (OPQOL-35)
contains 35 items tapping into eight domains including life overall, health, social relationships and participation, independence, control over life and freedom, home and neighborhood, psychological and emotional well-being, financial circumstances, culture and religion. The participant was asked to indicate the extent to which agreed with every single statement by choosing one of five possible options among "strongly disagree", "disagree", "neither agree nor disagree", "agree" and "strongly agree"
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jan 2026
- Study start1 Jan 2026
- Primary completion20 Apr 2026
- Study completion20 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Benign Prostate EnlargementStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The design of the study was randomized controlled trial (RCT), pre test, post test assessment.This study was carried out on seventy five male elderly patients diagnosed with benign prostatic hyperplasia. Their age ranged from 60 to 75 years old. The patients of this study were randomly assigned into three equal groups (n= 25): Group A (Study group): received pulsed electromagnetic field therapy in addition to medcial treatment program. Group B (Study group): received aerobic exercise training in addition to medical treatment program. Group C (Control group): received the medical treatment program only.
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 75 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, El-Sayed Essam, Cairo University
- Investigators
- El-Sayed Essam, Principal investigator, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07357168
- Sponsor's protocol ID
- (P.T.REC/012/004895)
- Status last verified
- Dec 2025
- First submitted
- 13 Jan 2026
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: because of its indivdual data
Study at a glance
From the registry record, last updated by the sponsor on 22 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Electromagnetic Field Therapy Versus Aerobic Exercise on Prostatic Function in Elderly With Benign Prostatic Hyperplasia
- ClinicalTrials.gov ID
- NCT07357168
- Acronym / sponsor ID
- (P.T.REC/012/004895)
- Conditions
- Benign Prostate Enlargement
- Keywords
- electromagnetic, prostaticenlargment, aerobicexercise
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 75 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 1 Jan 2026 (actual)
- Primary completion
- 20 Apr 2026 (actual)
- Study completion
- 20 Apr 2026 (actual)
- First posted
- 21 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will be carried out on seventy five elderly patients with benign prostatic hyperplasia. Their age will range from 60 to 75 years old. They will be recruited from Hoda Talaat Harb geriatric care center, Helwan governorate, Egypt. The aim of this study to investigate the effect of Electromagnetic field versus aerobic exercise on benign prostatic hyperplasia. Benign prostatic hyperplasia is a nonmalignant enlargement of the prostate gland and refers to the stromal and glandular epithelial hyperplasia that occurs in the transition zone of the prostate Clinically, the condition manifests with lower urinary tract symptoms (LUTS) consisting of obstructive (weak urination stream, incomplete bladder emptying, hesitancy) and irritative symptoms (frequency, urgency, nocturia). It is important to note that LUTS can result from a variety of conditions including problems relating to bladder innervation and aging as well as the outflow obstruction caused by BPH. LUTS due to BPH increases with age, BPH was primarily treated surgically for many years, however, in the 1990s this was superseded by the medical approaches that are now the front line therapy. 5α-reductase inhibitors such as finasteride and dutasteride and α-adrenergic blockers such as doxazosin and tamsulosin are used to shrink and relax the organ, respectively. The MTOPS study demonstrated that a combination of the α-blocker Doxazosin and the 5α-reductase inhibitor Finasteride are more effective at reducing LUTS progression than either drug given alone. While these approaches are effective in many patients, a significant proportion, in the range of 35%, showed progressive disease even in the face of the two drug combination,The Electromagnetic field is thought to have the ability to affect the cells that induce different cellular changes , present studies prove that molecular synergies may not remain the unique determinants implicated in the biological interface. EMF possesses numerous well-reported biological effects including inflammation and pain suppression. This therapy is noninvasive, secure, and easy to use for treating the origin of discomfort, damage, and inflammation
Detailed description
Benign prostatic hyperplasia (BPH) is a condition in which the prostate gland grows larger than normal, but the growth is not caused by cancer .The prostate has two main growth phases. The first growth phase happens early in puberty when the prostate doubles in size. The second growth phase starts around age 25 and continues throughout life. BPH often occurs late in the second growth phase Experts estimate that BPH affects 5% to 6% of men ages 40 to 64 and 29% to 33% of those ages 65 and older. BPH is the most common prostate problem in men older than age 50. BPH rarely causes symptoms in men younger than age 40,Benign prostatic hyperplasia (BPH) is a prostate volume (PV) enlargement due to a non-malignant cellular proliferation of the parenchyma and stroma of the gland, mainly in the transition area. BPH is a common age-related pathology, often causing lower urinary tract symptoms (LUTS) due to compression of the urethra by the enlarged prostate, which reduces the quality of life of affected patients , Pulsed electromagnetic field (PEMF) appears to act on BPH through anti-inflammatory and microvascular effects that can translate into symptomatic improvement. Experimental and translational work suggests PEMF improves prostate microcirculation and reduces tissue inflammation markers, which may decrease stromal/epithelial hyperplasia and interstitial edema-mechanisms that plausibly reduce prostate volume and obstructive lower urinary tract symptoms (LUTS). This proposed mechanism is supported by Doppler/ultrasound findings and physiologic measures reported in preclinical and human pilot studies showing improved prostatic blood flow and reduced inflammatory indices after PEMF treatment ,Regular physical exercise has been shown to positively influence benign prostatic hyperplasia (BPH), a common condition in aging men characterized by prostate enlargement and lower urinary tract symptoms (LUTS). The mechanisms by which exercise may improve BPH including hormonal modulation through reducing insulin-like growth factor-1 (IGF-1) and estrogen levels, both of which are linked to prostate growth, while increasing testosterone metabolism, potentially slowing BPH progression Physical activity (PA) has myriad health benefits, which may also extend to protection against BPH and LUTS development and progression. PA has been proposed to protect against BPH/LUTS by several possible mechanisms, including reducing body size, decreasing sympathetic nervous system activity ,The complications of benign prostatic hyperplasia may include: acute urinary retention, chronic, urinary retention, blood in the urine, urinary tract infections (UTIs), bladder damage and kidney damage Pulsed electromagnetic field therapy (PEMF) consists of low-frequency pulsed energy waves (1-50) Hz, that have been employed for many therapeutic purposes mainly because of its anti-inflammatory effect Moreover, many studies have shown that it is a safe procedure, without side effects ,Emerging evidence demonstrates that regular physical activity significantly enhances quality of life for men with benign prostatic hyperplasia (BPH). found that moderate-intensity aerobic exercise (30-60 minutes, 3-5 times weekly) improved International Prostate Symptom Score (IPSS) by an average of 3.2 points and quality of life scores by 1.5 points compared to sedentary controls. The study attributed these benefits to reduced prostatic inflammation and improved pelvic floor muscle function ,Human observational studies and reviews support that higher levels of physical activity-including aerobic modalities-are associated with lower odds of BPH and LUTS. A systematic review and meta analysis of observational studies found that compared to sedentary lifestyle, moderate to vigorous physical activity was linked to a significantly reduced risk of BPH/LUTS. While randomized controlled evidence remains limited and rated as very low certainty, some small trials (including tai chi and pelvic floor training) demonstrated improvements in symptom scores (e.g. IPSS reduction by ~6-8 points) when compared to waiting or conventional treatment. Together, these findings suggest that regular aerobic exercise may reduce urinary frequency, nocturia, urgency, and weak urinary stream associated with BPH, possibly via metabolic and anti inflammatory mechanisms ,The present study aimed to evaluate the comparative effects of pulsed electromagnetic field (PEMF) therapy and aerobic exercise training on prostatic function in elderly males diagnosed with benign prostatic hyperplasia (BPH). Seventy-five participants were randomly assigned into three equal groups: Group (A) received EMF therapy in addition to medical treatment program, Group (B) received aerobic exercise training in addition to medical treatment program, and Group (C) received medical treatment program alone. Baseline characteristics, including age and body mass index (BMI), revealed no statistically significant differences among the three groups, confirming their initial comparability. Following the intervention period, all groups demonstrated significant within-group improvements in clinical measures, including prostate volume, serum prostate-specific antigen (PSA), the International Prostate Symptom Score (IPSS), the American Urological Association Symptom Index (AUA-SI), and the Older People's Quality of Life Questionnaire (OPQOL-35). However, the extent of improvement varied across the groups,All groups showed significant improvements in prostate volume, PSA, IPSS, AUA-SI, and OPQOL-35 scores. However, Group (A) (PEMF) showed the most notable improvements, particularly in symptom scores and quality of life. These outcomes suggested that PEMF therapy may improve prostatic health by reducing inflammation, enhancing vascular function, and modulating cellular activity.
The findings aligned with emerging literature supporting PEMF's regenerative and anti-inflammatory effects, though its application in urology remains underexplored. This study provided promising evidence for incorporating PEMF therapy into physiotherapy for BPH, offering a safe, effective, and well-tolerated alternative to invasive management for elderly patients, This study provided strong evidence supporting that pulsed electromagnetic field (PEMF) therapy as an effective, non-invasive adjunct for managing Benign Prostatic Hyperplasia (BPH) in elderly men. PEMF improved both objective outcomes, such as prostate volume, and subjective measures, including LUTS and quality of life, without the adverse effects often associated with pharmacological or surgical treatments.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
- Model description
- The design of the study was randomized controlled trial (RCT), pre test, post test assessment.This study was carried out on seventy five male elderly patients diagnosed with benign prostatic hyperplasia. Their age ranged from 60 to 75 years old. The patients of this study were randomly assigned into three equal groups (n= 25): Group A (Study group): received pulsed electromagnetic field therapy in addition to medcial treatment program. Group B (Study group): received aerobic exercise training in addition to medical treatment program. Group C (Control group): received the medical treatment program only.
| Arm | Type | Receives |
|---|---|---|
| Pulsed electro magnetic field therapy | Active comparator | Device: pulsed electromagnetic fieldIt was applied for patients in the study group (A) only for 25 minutes per session, three times per week, for 12 consecutive weeks. |
| aerobic exercise training | Active comparator | Device: Treadmill machineIt was applied for patients in the study group (B) only. Each session started with 10 minutes of warm-up, followed by treadmill walking for up to 20-30 minutes and ended with a phase of 10 minutes of cool-down. |
| Routine medical treatment | Other | Device: pulsed electromagnetic field, Device: Treadmill machineIt was conducted for the three groups (A), (B), and (C). |
Who may qualify
- Ages
- 60 to 75 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Seventy five male elderly patients diagnosed with prostatic enlargement (prostate volume is greater than 40 mL) assessed by ultrasonography.
- They had benign prostatic hyperplasia indicated by a serum-based prostate-specific antigen (PSA) of 4.0 - 10 ng/mL
- They had moderate severity of benign prostatic hyperplasia indicated by a score of 8 to 19 according to the American Urological Association Symptom Index.
- They had lower urinary tract symptoms including nocturia, incomplete emptying of the bladder, urinary hesitancy, weak stream, frequency, and urgency leading to the development of acute urinary retention.
Key exclusion criteria (7 listed)
- Previous prostatic surgery.
- Urogenital malformations, genetic syndromes, and ongoing tumors.
- Uncontrolled hypertension
- Pacemakers and automatic implantable cardioverter defibrillators.
- Neurological disorders such as Parkinson's disease.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| pulsed electromagnetic fieldIt was applied for all patient in the study group (A) only for 25 minutes per session, three times per week, for 12 consecutive weeks | Device | Pulsed electro magnetic field therapy, Routine medical treatment |
| Treadmill machinewas applied for all patients in the study group (B) only. Each session started with 10 minutes of warm-up (dynamic stretching mainly of the lower limbs, ten right and left hip rotations, and ten arm rotations forward and backward), followed by treadmill walking for up to 20-30 minutes and ended with a phase of 10 minutes of cool-down. During the training, the patient was asked to correct the posture during walking with verbal instructions. | Device | Routine medical treatment, aerobic exercise training |
Primary outcome
prostate volume
Time frame: 12 weeks
This procedure required little to no special preparation, comfortable clothing. The patient was asked to wear a gown and to lie on his side with his knees toward his chest. To obtain high-quality images, an ultrasound transducer - a plastic cylinder about the size of a finger - was inserted a short distance into the rectum. The transducer was covered with a protective sheath and lubricated with gel.
2 secondary outcomes
International prostate symptom score (IPSS)
Time frame: 12 weeks
The Older People's Quality of Life Questionnaire (OPQOL-35)
Time frame: 12 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Oct 2026.
- Individual participant dataSharing planned: No. because of its indivdual data
Related trials for Benign Prostate Enlargement
Not yet recruiting
Anterior Bridge-Preserving Versus Conventional Early Apical Release in Bipolar Enucleation of the Prostate
Benign Prostatic Hyperplasia, Benign Prostatic Obstruction
Not yet recruitingPhase 3
Efficacy and Safety of Two Fixed-dose Combinations in Men With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. (BENIPRO)
Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
Not yet recruiting
Anterior Bridge-Preserving Versus Conventional Early Apical Release During Holmium Laser Enucleation of the Prostate
Benign Prostatic Hyperplasia, Benign Prostatic Obstruction
Recruiting
Learning Curve of Tri-lobar HoLEP Versus En-bloc HoLEP
Benign Prostatic Hyperplasia With Outflow Obstruction
RecruitingObservational study
Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
Benign Prostatic Hyperplasia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
El-Sayed Essam principal investigator
Cairo University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing pulsed electromagnetic field and Treadmill machine in people with Benign Prostate Enlargement, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
prostate volume (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.